^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

BTK mutation

i
Other names: BTK, Bruton Tyrosine Kinase, Bruton Agammaglobulinemia Tyrosine Kinase, Tyrosine-Protein Kinase BTK, Bruton'S Tyrosine Kinase, B-Cell Progenitor Kinase, AGMX1, ATK, BPK, Tyrosine-Protein Kinase BTK Isoform (Lacking Exon 13 To 17), Dominant-Negative Kinase-Deficient Brutons Tyrosine Kinase, Tyrosine-Protein Kinase BTK Isoform (Lacking Exon 14), Truncated Bruton Agammaglobulinemia Tyrosine Kinase, Agammaglobulinaemia Tyrosine Kinase, Agammaglobulinemia Tyrosine Kinase, PSCTK1, IGHD3, IMD1, XLA, AT
Entrez ID:
Related biomarkers:
Phase 1/2
ArQule, Inc., a subsidiary of Merck Sharp & Doh...
Active, not recruiting
Last update posted :
03/08/2024
Initiation :
06/26/2017
Primary completion :
09/12/2025
Completion :
09/12/2025
BCL2 • BCL6
|
BTK mutation • BCL6 translocation • BTK C481
|
nemtabrutinib (MK-1026)